Both in Biotechnology
Iovance Biotherapeutics vs CRISPR Therapeutics AG
Over the past year IOVA returned +330.5% and CRSP returned −19.6%; their daily moves had a correlation of 0.32.
IOVA +330.5% CRSP −19.6%Growth of $1, one year, split-adjusted
| Metric | IOVA | CRSP |
|---|---|---|
| Price | $8.48 | $51.42 |
| Market cap | $3.84B | $4.97B |
| Today | −11.30% | −5.23% |
| 1 month | −40.4% | −7.3% |
| 6 months | +149.4% | −0.4% |
| Year to date | +210.6% | −1.9% |
| 1 year | +324.0% | −17.8% |
| Revenue growth (YoY) | +65.7% | +1041.4% |
| Gross margin | 56.1% | 100.0% |
| Net margin | −47.6% | −895.3% |
| P/E (TTM) | — | — |
| Price / sales | 11.8× | 371.3× |
| Net cash | $297.7M | $1.78B |
| Dividend yield | — | — |
| Volatility (60d) | 128.2% | 53.4% |
| Short % of float | 15.2% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).